Page last updated: 2024-08-16

ranitidine and Skin Neoplasms

ranitidine has been researched along with Skin Neoplasms in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (40.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	3 (60.00)	2.80

Authors

Authors	Studies
Kordeva, S; Tchernev, G	1
Duarte-Salles, T; Falconer, T; Hripcsak, G; Hsu, JC; Hsu, MH; Kim, Y; Ko, H; Lee, HL; Nguyen, PA; Park, CH; Park, RW; Posada, JD; Pratt, N; Prieto-Alhambra, D; Reich, CG; Seager, S; Seo, SI; Shah, NH; Shin, WG; Suchard, MA; Van Zandt, M; Yanover, C; You, SC	1
Ekobena, P; Ivanyuk, A; Livio, F	1
Le Gros, G; Parsons, PG; Zhang, XM	1
Lohmann, RC; Mertens, WC	1

Reviews

2 review(s) available for ranitidine and Skin Neoplasms

Article	Year
Ranitidine Use and Incident Cancer in a Multinational Cohort. JAMA network open, 2023, 09-05, Volume: 6, Issue:9 Topics: Cohort Studies; Female; Histamine H2 Antagonists; Humans; Male; Middle Aged; Ranitidine; Skin Neoplasms; Thyroid Neoplasms	2023
[Pharmacovigilance update]. Revue medicale suisse, 2021, Jan-13, Volume: 17, Issue:720-1 Topics: Adenosine Monophosphate; Alanine; Cleft Lip; Contraindications, Drug; COVID-19 Drug Treatment; Cytokine Release Syndrome; Female; Fingolimod Hydrochloride; Humans; Hydroxychloroquine; Leiomyoma; Norpregnadienes; Pharmacokinetics; Pharmacovigilance; Pregnancy; Ranitidine; Safety-Based Drug Withdrawals; Skin Neoplasms	2021

Article

Year

Ranitidine Use and Incident Cancer in a Multinational Cohort.

JAMA network open, 2023, 09-05, Volume: 6, Issue:9

Topics: Cohort Studies; Female; Histamine H2 Antagonists; Humans; Male; Middle Aged; Ranitidine; Skin Neoplasms; Thyroid Neoplasms

2023

[Pharmacovigilance update].

Revue medicale suisse, 2021, Jan-13, Volume: 17, Issue:720-1

Topics: Adenosine Monophosphate; Alanine; Cleft Lip; Contraindications, Drug; COVID-19 Drug Treatment; Cytokine Release Syndrome; Female; Fingolimod Hydrochloride; Humans; Hydroxychloroquine; Leiomyoma; Norpregnadienes; Pharmacokinetics; Pharmacovigilance; Pregnancy; Ranitidine; Safety-Based Drug Withdrawals; Skin Neoplasms

2021

Trials

1 trial(s) available for ranitidine and Skin Neoplasms

Article	Year
Oral indomethacin and ranitidine in advanced melanoma: a phase II study. Clinical oncology (Royal College of Radiologists (Great Britain)), 1996, Volume: 8, Issue:2 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Female; Follow-Up Studies; Histamine H2 Antagonists; Humans; Indomethacin; Liver Neoplasms; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Pelvis; Ranitidine; Remission Induction; Skin Neoplasms; Uveal Neoplasms	1996

Article

Year

Oral indomethacin and ranitidine in advanced melanoma: a phase II study.

Clinical oncology (Royal College of Radiologists (Great Britain)), 1996, Volume: 8, Issue:2

Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Female; Follow-Up Studies; Histamine H2 Antagonists; Humans; Indomethacin; Liver Neoplasms; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Pelvis; Ranitidine; Remission Induction; Skin Neoplasms; Uveal Neoplasms

1996

Other Studies

2 other study(ies) available for ranitidine and Skin Neoplasms

Article	Year
MULTIPLE BCCS AND DYSPLASTIC NEVI AFTER ACE INHIBITORS (ENALAPRIL/PERINDOPRIL): THE ROLE OF NITROSAMINE CONTAMINATION/AVAILABILITY AS SUBSTANTIAL SKIN CANCER TRIGGERING FACTOR. Georgian medical news, 2023, Issue:335 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Carcinogens; Dysplastic Nevus Syndrome; Enalapril; Humans; Hydrochlorothiazide; Mutagens; Nitrosamines; Perindopril; Pharmaceutical Preparations; Ranitidine; Skin Neoplasms	2023
Alteration of tyrosinase activity in human melanocytes and melanoma cells by histamine H2 and H3 ligands. Melanoma research, 1994, Volume: 4, Issue:6 Topics: Brain Neoplasms; Cell Line; Cell Survival; Enzyme Induction; Histamine Agonists; Histamine H2 Antagonists; Humans; Ligands; Melanocytes; Melanoma, Amelanotic; Monophenol Monooxygenase; Neoplasm Proteins; Protein Biosynthesis; Ranitidine; Receptors, Histamine H2; Receptors, Histamine H3; RNA; RNA, Neoplasm; Skin Neoplasms; Time Factors; Tumor Cells, Cultured	1994

Article

Year

MULTIPLE BCCS AND DYSPLASTIC NEVI AFTER ACE INHIBITORS (ENALAPRIL/PERINDOPRIL): THE ROLE OF NITROSAMINE CONTAMINATION/AVAILABILITY AS SUBSTANTIAL SKIN CANCER TRIGGERING FACTOR.

Georgian medical news, 2023, Issue:335

Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Carcinogens; Dysplastic Nevus Syndrome; Enalapril; Humans; Hydrochlorothiazide; Mutagens; Nitrosamines; Perindopril; Pharmaceutical Preparations; Ranitidine; Skin Neoplasms

2023

Alteration of tyrosinase activity in human melanocytes and melanoma cells by histamine H2 and H3 ligands.

Melanoma research, 1994, Volume: 4, Issue:6

Topics: Brain Neoplasms; Cell Line; Cell Survival; Enzyme Induction; Histamine Agonists; Histamine H2 Antagonists; Humans; Ligands; Melanocytes; Melanoma, Amelanotic; Monophenol Monooxygenase; Neoplasm Proteins; Protein Biosynthesis; Ranitidine; Receptors, Histamine H2; Receptors, Histamine H3; RNA; RNA, Neoplasm; Skin Neoplasms; Time Factors; Tumor Cells, Cultured

1994